Drug Safety Oversight Board Meeting: October 2, 2007 Public Summary

The Board held a meeting at the request of the Director of the Center for Drug Evaluation and Research (CDER) to provide advice on an internal difference of opinion regarding a post-marketing safety concern and options for regulatory action.